Cancer Gene Therapy Market to grow at 20.7% CAGR from 2016 to 2024 - PowerPoint PPT Presentation

About This Presentation

Cancer Gene Therapy Market to grow at 20.7% CAGR from 2016 to 2024


Get more details @ Companies operating in carcinoembryonic antigen market includes Abbott Diagnostics, Roche Diagnostics, Quest Diagnostics and GenWay Biotech. Companies operating in this industry are focusing on strategies such as mergers and acquisitions to maintain leadership position. – PowerPoint PPT presentation

Number of Views:65


Transcript and Presenter's Notes

Title: Cancer Gene Therapy Market to grow at 20.7% CAGR from 2016 to 2024

Global Cancer Gene Therapy Market share to grow
at 20.7 CAGR from 2016 to 2024 Global Market
Insights Inc.
Fuel Cell Market size worth 25.5bn by 2024
Key Insights from Cancer Gene Therapy Market
  • Global Market Insights, Inc., says Cancer gene
    therapy industry revenue, which was assessed at
    USD 805.5 million in 2015, is projected to hit
    USD 4.3 billion by 2024.
  • A significant rise in the number of cancer
    incidences has led to the deployment of genome
    technologies, which will spur Cancer Gene Therapy
    Market size.
  • Heavy funding by the government for cancer
    research programs and beneficial schemes favoring
    cancer screening programs are expected to produce
    lucrative avenues for cancer gene therapy market.
  • Considering the regional trends, cancer gene
    therapy industry in China, which accounted for
    35 of Asia Pacific cancer gene therapy market
    share in 2015, is projected to record a CAGR of
    21 over the next few years, having collected a
    revenue of USD 99.6 million in 2015.
  • Cancer gene therapy market in Japan, worth USD
    78.2 million in 2015, is projected to expand at a
    CAGR of 20.9 over the period from 2016 to 2024.

  • UK cancer gene therapy industry, which was
    assessed at USD 92 million in 2015, is set to
    grow at an annual rate of 20.8 over the coming
    seven years, subject to high frequency of cancer
    among the nations population along with the
    acceptance of modern treatment methodologies.
  • U.S. cancer gene therapy industry, which
    contributed more than 95 of North America cancer
    gene therapy market revenue in 2015, is projected
    to grow at a rate of 20.9 over the coming seven
  • Cancer gene therapies comprise gene transfer,
    oncolytic virotherapy, and gene induced
  • NewLink Genetics Corporation, ZIOPHARM Oncology
    Incorporation, Shenzhen Sibiono GeneTech Company
    Limited, Genelux Corporation, Gradalis
    Incorporation, Altor Bioscience Corporation,
    Shanghai Sunway Biotech Company Limited, Amgenen
    Incorporation, MultiVir Incorporation, Aduro
    Biotech Incorporation, OncoGeneX Pharmaceuticals
    Company, GlobeImmune Incorporation, MolMed
    S.p.A., and BioCancell Therapeutic Incorporation
    are the few of the established players of cancer
    gene therapy industry.

U.S. Cancer Gene Therapy Market size, by type,
2012 - 2024 (USD Million)


Browse Full Market Research Report On Cancer
Gene Therapy Market _at_ http//
Request for a Sample of this Research
Report _at_ https//
/detail/763 https//
Table of Content

Chapter 1. Methodology and Scope 1.1. Research
Methodology 1.1.1. Initial data
exploration 1.1.2. Statistical modeling and
forecast 1.1.3. Industry insights and
validation 1.1.4. Research scope assumptions
1.2. Data Sources Chapter 2. Executive
Summary 2.1. Cancer genetics industry 3600
synopsis, 2012 - 2024 2.1.1. Business
trends 2.1.2. Regional trends 2.1.3.
Application trends Chapter 3. Cancer Gene
Therapy Industry Insights 3.1. Industry
Table of Content
3.2. IIndustry Size and forecast, 2012 -
2024 3.3. Industry Impact forces 3.3.1.
Growth drivers Technological
advancements Increased adoption of
nanotechnology Favorable
government regulations 3.3.2. Industry
pitfalls challenges High cost of
cancer genetherapy 3.4. Growth potential
analysis 3.5. Porters analysis 3.6. Key
opportunities prioritized, 2015 3.7. PESTEL
analysis 3.8. Regulatory Landscape 3.8.1.
U.S. 3.8.2. EU 3.8.3. China
Table of Content
3.9. Scientific and Ethical issues in Gene
Therapy 3.10. Competitive landscape, 2015 3.11.
Pipeline Analysis by cancer type 3.11.1.
Head and Neck Cancer Pipeline Analysis 3.11.2.
Breast Cancer Pipeline Analysis 3.11.3.
Gastro Intestinal Cancer Pipeline
Analysis 3.11.4. Gentiourinary Cancer
Pipeline Analysis 3.11.5. Gynecological
Cancer Pipeline Analysis 3.11.6.
Haemotological Cancer Pipeline Analysis 3.11.7.
Neurologic Cancer Pipeline Analysis 3.11.8.
Respiratory Cancer Pipeline Analysis 3.11.9.
Skin Cancer Pipeline Analysis
Stay In Touch Website Soci
al Media
Write a Comment
User Comments (0)